How should I apply the DSM‑5 criteria to diagnose a psychiatric disorder in a patient?

Applying DSM-5 Criteria in Clinical Practice

Apply DSM-5 diagnostic criteria systematically by ensuring symptoms meet both the specific symptom count/duration requirements AND represent true internal dysfunction rather than normal reactions to life circumstances, using the disorder-specific criteria sets while incorporating specifiers to capture the full clinical picture 1, 2.

Core Diagnostic Approach

The DSM-5 requires a two-step verification process for any psychiatric diagnosis:

1. Meet the specific symptom criteria for the disorder (number, type, and duration of symptoms)
2. Demonstrate internal dysfunction - symptoms must indicate pathology, not normal human responses 3

Distinguishing Dysfunction from Normal Experience

This is the critical challenge: virtually every psychiatric symptom can occur in normally functioning people under certain circumstances 3. The DSM-5 criteria sets employ specific strategies to ensure symptoms indicate true pathology:

• Duration and persistence requirements - symptoms must last beyond what's expected for normal reactions
• Frequency/intensity thresholds - symptoms must exceed normal population ranges
• Disproportionality - symptoms must be excessive relative to the triggering context
• Pervasiveness - symptoms must occur across multiple contexts, not just one situation
• Context exclusions - criteria explicitly exclude scenarios where symptoms represent normal reactions
• Symptom clustering - requiring multiple symptoms increases the likelihood of true pathology
• Minimum thresholds - requiring enough symptoms to meet diagnostic confidence 3

Substance-Related Considerations

When psychiatric symptoms co-occur with substance use, apply these specific rules 1:

• Substance/medication-induced disorders must "resemble" the full criteria for the relevant psychiatric disorder
• The substance must be pharmacologically capable of producing the observed symptoms
• Remove the old requirement that symptoms must "exceed expected intoxication/withdrawal" - this proved too complex and unreliable
• Use the same duration and symptom criteria as the corresponding independent (non-substance-induced) disorder
• Distinguish "independent" disorders (formerly called "primary") from substance-induced ones based on temporal patterns

Common pitfall: The DSM-5 ultimately adopted a flexible approach lacking specific symptom and duration requirements for substance-induced disorders due to concerns from various work groups, creating diagnostic ambiguity 1.

Utilizing Specifiers for Precision

Specifiers are essential tools that move diagnosis toward a dimensional approach and have demonstrated clinical utility in ordinary practice 2. After establishing the core diagnosis:

• Apply severity ratings (mild, moderate, severe)
• Add relevant specifiers (e.g., with anxious distress, with mixed features, with melancholic features)
• Document cross-cutting symptoms that don't fit neatly into one category

For major depressive disorder specifically, symptom patterns provide severity clues 4:

• Moderate depression: Depressed mood as main criterion + somatic symptoms (sleep, appetite, psychomotor, fatigue, concentration)
• Severe depression: Anhedonia as main criterion + non-somatic symptoms (worthlessness, guilt, suicidal ideation)

This distinction has treatment implications - moderate depression with somatic features may indicate autonomic dysfunction and cardiovascular risk, while severe depression with non-somatic features signals suicide risk 4.

Critical Implementation Caveat

Research shows significant discrepancies between clinical diagnoses and structured interview diagnoses, indicating clinicians often don't systematically apply DSM criteria as written 5. To avoid this pitfall:

• Explicitly review each criterion for the suspected disorder
• Document which specific criteria are met
• Don't rely on gestalt impressions or pattern recognition alone
• Consider using structured or semi-structured interviews for complex cases

Biomarkers Are Not Diagnostic

Despite interest in biological markers, no genetic variants, drug metabolite tests, or brain imaging findings can currently diagnose substance use disorders or other psychiatric conditions 1. These may predict treatment response but cannot replace clinical criteria.